Acura Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acura pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acura Pharmaceuticals Today - Breaking & Trending Today

Acura Pharmaceuticals (OTCMKTS:ACUR) Stock Crosses Above 200 Day Moving Average of $0.00

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.03. Acura Pharmaceuticals shares last traded at $0.03, with a volume of 103 shares changing hands. Acura Pharmaceuticals Price Performance […] ....

United States , Acura Pharmaceuticals , Acura Pharmaceuticals Inc , Acura Pharmaceuticals Company Profile , News Ratings For Acura Pharmaceuticals Daily , Acura Pharmaceuticals Price Performance , Get Free Report , Acura Pharmaceuticals Daily ,

Acura Pharmaceuticals (OTCMKTS:ACUR) Stock Price Crosses Above 200 Day Moving Average of $0.00

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.01. Acura Pharmaceuticals shares last traded at $0.01, with a volume of 20,000 shares traded. Acura […] ....

United States , News Ratings For Acura Pharmaceuticals Daily , Acura Pharmaceuticals Stock Performance , Acura Pharmaceuticals Inc , Acura Pharmaceuticals , Get Free Report , Acura Pharmaceuticals Daily , Otcmkts Acur ,

Acura Pharmaceuticals : TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT - Form 8-K -March 26, 2024 at 01:10 pm EDT

TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT

This AMENDMENT #8 TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT dated June 28, 2019 between Acura. ....

State Of New York , New York , United States , John Schutte , Robert Jones , Acura Pharmaceuticals Inc , N North Court , Abuse Deterrent Pharma , Abuse Deterrent Pharma Llc Ad , Acura Pharmaceuticals , Regulatory Submission , Regulatory Application Submission , Regulatory Approval Application , Deterrent Pharma ,

Honda recalls 2.6 million US vehicles due to possible fuel pump failure

Honda is recalling 2.6 million vehicles in the United States due to the fuel pump possibly failing. ....

United States , Toyota Camry , Honda Motor Co , Toyota Motor Corporation , Business Finance , Acura Pharmaceuticals , Toyota Vehicle Recalls , Mid Size Cars , Takata Corporation ,

Acura Pharmaceuticals : AMENDED, CONSOLIDATED AND RESTATED SECURED PROMISSORY NOTE - Form 8-K -December 21, 2023 at 12:03 pm EST

AMENDED, CONSOLIDATED AND RESTATED

SECURED PROMISSORY NOTE

This AMENDMENT #1 TO AMENDED, CONSOLIDATED AND RESTATED SECURED PROMISSSORY NOTE dated November 10,. ....

United States , New York , Petera Clemens , John Schutte , N North Court , Acura Pharmaceuticals Inc , Abuse Deterrent Pharma Llc Ad , Abuse Deterrent Pharma , Acura Pharmaceuticals , Maturity Date , Deterrent Pharma ,